Expertise in
4
conditions

Ling P. Jin

State Key Laboratory Of Vascular Homeostasis And Remodeling, NHC Key Laboratory Of Cardiovascular Molecular Biology And Regulatory Peptides, Beijing Key Laboratory Of Cardiovascular Receptors Research, 
Beijing, CN 
Expertise in
4
conditions
State Key Laboratory Of Vascular Homeostasis And Remodeling, NHC Key Laboratory Of Cardiovascular Molecular Biology And Regulatory Peptides, Beijing Key Laboratory Of Cardiovascular Receptors Research, 
Beijing, CN 

Overview

Ling Jin practices practicing medicine in Beijing, China.

Ms. Jin is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Burkitt Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, Glucocorticoid-Remediable Aldosteronism, and Ileostomy.

She is actively involved in clinical research, co-authoring 122 peer reviewed articles.

Gender

Female

Locations

State Key Laboratory Of Vascular Homeostasis And Remodeling, NHC Key Laboratory Of Cardiovascular Molecular Biology And Regulatory Peptides, Beijing Key Laboratory Of Cardiovascular Receptors Research, Beijing, 100871, China
Other Locations
No.300, Guangzhou Street, Nanjing, 210029, China
Changsha, 410008, China
Tianjin, China
Shanghai, 201210, China
Jingmen, China
Yicheng, China
Hong Kong, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

122 Total Publications

Clinical study of brentuximab vedotin combined with the ifosfamide and gemcitabine regimen in the treatment of children with relapsed or refractory classic Hodgkin lymphoma
Clinical study of brentuximab vedotin combined with the ifosfamide and gemcitabine regimen in the treatment of children with relapsed or refractory classic Hodgkin lymphoma
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: August 17, 2026

Frequently Asked Questions about Ling P. Jin

Is Ling P. Jin a top-rated expert for Burkitt Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Ling P. Jin is classified as an Distinguished expert for Burkitt Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ling P. Jin participate in research or clinical trials?

Yes. Ling P. Jin has published 122 articles and abstracts on conditions like Burkitt Lymphoma. You can view a list of Ling P. Jin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Jin's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile